核医学診断（SPECTおよびPET）の世界市場 2020年：メーカー別、地域別、種類・用途別

• 英文タイトル：Global Nuclear Medicine Diagnostic (SPECT and PET) Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-09141 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、101ページ • 納品方法：Eメール • 産業分類：医療機器・医療消耗品

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、核医学診断（SPECTおよびPET）の世界市場を広く調査・分析し、今後の市場展望をまとめております。核医学診断（SPECTおよびPET）の種類別市場規模（SPECT、PET）、用途別市場規模（腫瘍、循環器、神経、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：GE Healthcare、MIE、Mediso、Siemens Healthineers、SurgicEye、Philips Healthcare、Bruker、Spectrum Dynamics、MILabs ・地域別グローバル市場分析 2015年-2020年 ・核医学診断（SPECTおよびPET）の北米市場（アメリカ、カナダ、メキシコ） ・核医学診断（SPECTおよびPET）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・核医学診断（SPECTおよびPET）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・核医学診断（SPECTおよびPET）の南米市場（ブラジル、アルゼンチン） ・核医学診断（SPECTおよびPET）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：SPECT、PET ・用途別分析：腫瘍、循環器、神経、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global Nuclear Medicine Diagnostic (SPECT and PET) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Nuclear Medicine Diagnostic (SPECT and PET) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Nuclear Medicine Diagnostic (SPECT and PET) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Nuclear Medicine Diagnostic (SPECT and PET) market has been segmented into
SPECT
PET

By Application, Nuclear Medicine Diagnostic (SPECT and PET) has been segmented into:
Oncology
Cardiology
Neurology
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nuclear Medicine Diagnostic (SPECT and PET) market presented in the report. This section sheds light on the sales growth of different regional and country-level Nuclear Medicine Diagnostic (SPECT and PET) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nuclear Medicine Diagnostic (SPECT and PET) market.

The report offers in-depth assessment of the growth and other aspects of the Nuclear Medicine Diagnostic (SPECT and PET) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Nuclear Medicine Diagnostic (SPECT and PET) Market Share Analysis
Nuclear Medicine Diagnostic (SPECT and PET) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nuclear Medicine Diagnostic (SPECT and PET) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nuclear Medicine Diagnostic (SPECT and PET) sales, revenue and market share for each player covered in this report.

The major players covered in Nuclear Medicine Diagnostic (SPECT and PET) are:
GE Healthcare
MIE
Mediso
Siemens Healthineers
SurgicEye
Philips Healthcare
Bruker
Spectrum Dynamics
MILabs

Among other players domestic and global, Nuclear Medicine Diagnostic (SPECT and PET) market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nuclear Medicine Diagnostic (SPECT and PET) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nuclear Medicine Diagnostic (SPECT and PET), with price, sales, revenue and global market share of Nuclear Medicine Diagnostic (SPECT and PET) in 2018 and 2019.
Chapter 3, the Nuclear Medicine Diagnostic (SPECT and PET) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nuclear Medicine Diagnostic (SPECT and PET) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Nuclear Medicine Diagnostic (SPECT and PET) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Nuclear Medicine Diagnostic (SPECT and PET) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

Table of Contents

1 Market Overview
1.1 Nuclear Medicine Diagnostic (SPECT and PET) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 SPECT
1.2.3 PET
1.3 Market Analysis by Application
1.3.1 Overview: Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Neurology
1.3.5 Others
1.4 Overview of Global Nuclear Medicine Diagnostic (SPECT and PET) Market
1.4.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GE Healthcare
2.1.1 GE Healthcare Details
2.1.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GE Healthcare SWOT Analysis
2.1.4 GE Healthcare Product and Services
2.1.5 GE Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 MIE
2.2.1 MIE Details
2.2.2 MIE Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 MIE SWOT Analysis
2.2.4 MIE Product and Services
2.2.5 MIE Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Mediso
2.3.1 Mediso Details
2.3.2 Mediso Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Mediso SWOT Analysis
2.3.4 Mediso Product and Services
2.3.5 Mediso Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Siemens Healthineers
2.4.1 Siemens Healthineers Details
2.4.2 Siemens Healthineers Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Siemens Healthineers SWOT Analysis
2.4.4 Siemens Healthineers Product and Services
2.4.5 Siemens Healthineers Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 SurgicEye
2.5.1 SurgicEye Details
2.5.2 SurgicEye Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 SurgicEye SWOT Analysis
2.5.4 SurgicEye Product and Services
2.5.5 SurgicEye Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Philips Healthcare
2.6.1 Philips Healthcare Details
2.6.2 Philips Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Philips Healthcare SWOT Analysis
2.6.4 Philips Healthcare Product and Services
2.6.5 Philips Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bruker
2.7.1 Bruker Details
2.7.2 Bruker Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bruker SWOT Analysis
2.7.4 Bruker Product and Services
2.7.5 Bruker Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Spectrum Dynamics
2.8.1 Spectrum Dynamics Details
2.8.2 Spectrum Dynamics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Spectrum Dynamics SWOT Analysis
2.8.4 Spectrum Dynamics Product and Services
2.8.5 Spectrum Dynamics Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 MILabs
2.9.1 MILabs Details
2.9.2 MILabs Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 MILabs SWOT Analysis
2.9.4 MILabs Product and Services
2.9.5 MILabs Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Nuclear Medicine Diagnostic (SPECT and PET) Manufacturer Market Share in 2019
3.3.2 Top 6 Nuclear Medicine Diagnostic (SPECT and PET) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales, Revenue and Market Share by Regions
4.1.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales and Market Share by Regions (2015-2020)
4.1.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue and Market Share by Regions (2015-2020)
4.2 North America Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
4.3 Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
4.5 South America Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Nuclear Medicine Diagnostic (SPECT and PET) Sales, Revenue and Market Share by Country
5.1.1 North America Nuclear Medicine Diagnostic (SPECT and PET) Sales and Market Share by Country (2015-2020)
5.1.2 North America Nuclear Medicine Diagnostic (SPECT and PET) Revenue and Market Share by Country (2015-2020)
5.2 United States Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
5.3 Canada Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
5.4 Mexico Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales, Revenue and Market Share by Country
6.1.1 Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales and Market Share by Country (2015-2020)
6.1.2 Europe Nuclear Medicine Diagnostic (SPECT and PET) Revenue and Market Share by Country (2015-2020)
6.2 Germany Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
6.3 UK Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
6.4 France Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
6.5 Russia Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
6.6 Italy Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Revenue and Market Share by Regions (2015-2020)
7.2 China Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
7.3 Japan Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
7.4 Korea Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
7.5 India Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
7.7 Australia Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Nuclear Medicine Diagnostic (SPECT and PET) Sales, Revenue and Market Share by Country
8.1.1 South America Nuclear Medicine Diagnostic (SPECT and PET) Sales and Market Share by Country (2015-2020)
8.1.2 South America Nuclear Medicine Diagnostic (SPECT and PET) Revenue and Market Share by Country (2015-2020)
8.2 Brazil Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
8.3 Argentina Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Nuclear Medicine Diagnostic (SPECT and PET) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
9.3 Turkey Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
9.4 Egypt Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
9.5 South Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales and Market Share by Type (2015-2020)
10.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue and Market Share by Type (2015-2020)
10.3 Global Nuclear Medicine Diagnostic (SPECT and PET) Price by Type (2015-2020)
11 Global Nuclear Medicine Diagnostic (SPECT and PET) Market Segment by Application
11.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Application (2015-2020)
11.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Application (2015-2020)
11.3 Global Nuclear Medicine Diagnostic (SPECT and PET) Price by Application (2015-2020)
12 Market Forecast
12.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales, Revenue and Growth Rate (2021-2025)
12.2 Nuclear Medicine Diagnostic (SPECT and PET) Market Forecast by Regions (2021-2025)
12.2.1 North America Nuclear Medicine Diagnostic (SPECT and PET) Market Forecast (2021-2025)
12.2.2 Europe Nuclear Medicine Diagnostic (SPECT and PET) Market Forecast (2021-2025)
12.2.3 Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Market Forecast (2021-2025)
12.2.4 South America Nuclear Medicine Diagnostic (SPECT and PET) Market Forecast (2021-2025)
12.2.5 Middle East & Africa Nuclear Medicine Diagnostic (SPECT and PET) Market Forecast (2021-2025)
12.3 Nuclear Medicine Diagnostic (SPECT and PET) Market Forecast by Type (2021-2025)
12.3.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Forecast by Type (2021-2025)
12.3.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Market Share Forecast by Type (2021-2025)
12.4 Nuclear Medicine Diagnostic (SPECT and PET) Market Forecast by Application (2021-2025)
12.4.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Forecast by Application (2021-2025)
12.4.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nuclear Medicine Diagnostic (SPECT and PET) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 8. GE Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Major Business
Table 9. GE Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Total Revenue (USD Million) (2018-2019)
Table 10. GE Healthcare SWOT Analysis
Table 11. GE Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Product and Services
Table 12. GE Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. MIE Basic Information, Manufacturing Base and Competitors
Table 14. MIE Nuclear Medicine Diagnostic (SPECT and PET) Major Business
Table 15. MIE Nuclear Medicine Diagnostic (SPECT and PET) Total Revenue (USD Million) (2018-2019)
Table 16. MIE SWOT Analysis
Table 17. MIE Nuclear Medicine Diagnostic (SPECT and PET) Product and Services
Table 18. MIE Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Mediso Basic Information, Manufacturing Base and Competitors
Table 20. Mediso Nuclear Medicine Diagnostic (SPECT and PET) Major Business
Table 21. Mediso Nuclear Medicine Diagnostic (SPECT and PET) Total Revenue (USD Million) (2018-2019)
Table 22. Mediso SWOT Analysis
Table 23. Mediso Nuclear Medicine Diagnostic (SPECT and PET) Product and Services
Table 24. Mediso Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 26. Siemens Healthineers Nuclear Medicine Diagnostic (SPECT and PET) Major Business
Table 27. Siemens Healthineers Nuclear Medicine Diagnostic (SPECT and PET) Total Revenue (USD Million) (2018-2019)
Table 28. Siemens Healthineers SWOT Analysis
Table 29. Siemens Healthineers Nuclear Medicine Diagnostic (SPECT and PET) Product and Services
Table 30. Siemens Healthineers Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. SurgicEye Basic Information, Manufacturing Base and Competitors
Table 32. SurgicEye Nuclear Medicine Diagnostic (SPECT and PET) Major Business
Table 33. SurgicEye Nuclear Medicine Diagnostic (SPECT and PET) Total Revenue (USD Million) (2018-2019)
Table 34. SurgicEye SWOT Analysis
Table 35. SurgicEye Nuclear Medicine Diagnostic (SPECT and PET) Product and Services
Table 36. SurgicEye Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Philips Healthcare Basic Information, Manufacturing Base and Competitors
Table 38. Philips Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Major Business
Table 39. Philips Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Total Revenue (USD Million) (2018-2019)
Table 40. Philips Healthcare SWOT Analysis
Table 41. Philips Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Product and Services
Table 42. Philips Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Bruker Basic Information, Manufacturing Base and Competitors
Table 44. Bruker Nuclear Medicine Diagnostic (SPECT and PET) Major Business
Table 45. Bruker Nuclear Medicine Diagnostic (SPECT and PET) Total Revenue (USD Million) (2018-2019)
Table 46. Bruker SWOT Analysis
Table 47. Bruker Nuclear Medicine Diagnostic (SPECT and PET) Product and Services
Table 48. Bruker Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Spectrum Dynamics Basic Information, Manufacturing Base and Competitors
Table 50. Spectrum Dynamics Nuclear Medicine Diagnostic (SPECT and PET) Major Business
Table 51. Spectrum Dynamics Nuclear Medicine Diagnostic (SPECT and PET) Total Revenue (USD Million) (2018-2019)
Table 52. Spectrum Dynamics SWOT Analysis
Table 53. Spectrum Dynamics Nuclear Medicine Diagnostic (SPECT and PET) Product and Services
Table 54. Spectrum Dynamics Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. MILabs Basic Information, Manufacturing Base and Competitors
Table 56. MILabs Nuclear Medicine Diagnostic (SPECT and PET) Major Business
Table 57. MILabs Nuclear Medicine Diagnostic (SPECT and PET) Total Revenue (USD Million) (2018-2019)
Table 58. MILabs SWOT Analysis
Table 59. MILabs Nuclear Medicine Diagnostic (SPECT and PET) Product and Services
Table 60. MILabs Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Manufacturer (2018-2019) (K Units)
Table 62. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Regions (2015-2020) (K Units)
Table 64. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Regions (2015-2020)
Table 65. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Countries (2015-2020) (K Units)
Table 67. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Countries (2015-2020)
Table 68. North America Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Countries (2015-2020)
Table 70. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales by Countries (2015-2020) (K Units)
Table 71. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Countries (2015-2020)
Table 72. Europe Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales by Regions (2015-2020) (K Units)
Table 74. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Countries (2015-2020) (K Units)
Table 77. South America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Countries (2015-2020)
Table 78. South America Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales by Countries (2015-2020) (K Units)
Table 81. Middle East & Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Countries (2015-2020)
Table 84. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2015-2020) (K Units)
Table 85. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Share by Type (2015-2020)
Table 86. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Type (2015-2020) (USD Million)
Table 87. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue Share by Type (2015-2020)
Table 88. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2015-2020) (K Units)
Table 89. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Share by Application (2015-2020)
Table 90. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Forecast by Regions (2021-2025) (K Units)
Table 91. Global Nuclear Medicine Diagnostic (SPECT and PET) Market Share Forecast by Regions (2021-2025)
Table 92. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Forecast by Type (2021-2025) (K Units)
Table 93. Global Nuclear Medicine Diagnostic (SPECT and PET) Market Share Forecast by Type (2021-2025)
Table 94. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Forecast by Application (2021-2025)
Table 95. Global Nuclear Medicine Diagnostic (SPECT and PET) Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Nuclear Medicine Diagnostic (SPECT and PET) Picture
Figure 2. Global Sales Market Share of Nuclear Medicine Diagnostic (SPECT and PET) by Type in 2019
Figure 3. SPECT Picture
Figure 4. PET Picture
Figure 5. Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Application in 2018
Figure 6. Oncology Picture
Figure 7. Cardiology Picture
Figure 8. Neurology Picture
Figure 9. Others Picture
Figure 10. Global Nuclear Medicine Diagnostic (SPECT and PET) Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Nuclear Medicine Diagnostic (SPECT and PET) Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Nuclear Medicine Diagnostic (SPECT and PET) Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Nuclear Medicine Diagnostic (SPECT and PET) Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Nuclear Medicine Diagnostic (SPECT and PET) Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Nuclear Medicine Diagnostic (SPECT and PET) Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Nuclear Medicine Diagnostic (SPECT and PET) Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Nuclear Medicine Diagnostic (SPECT and PET) Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Nuclear Medicine Diagnostic (SPECT and PET) Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Nuclear Medicine Diagnostic (SPECT and PET) Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Nuclear Medicine Diagnostic (SPECT and PET) Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Nuclear Medicine Diagnostic (SPECT and PET) Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Nuclear Medicine Diagnostic (SPECT and PET) Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Nuclear Medicine Diagnostic (SPECT and PET) Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Nuclear Medicine Diagnostic (SPECT and PET) Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Nuclear Medicine Diagnostic (SPECT and PET) Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Nuclear Medicine Diagnostic (SPECT and PET) Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Nuclear Medicine Diagnostic (SPECT and PET) Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Nuclear Medicine Diagnostic (SPECT and PET) Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Nuclear Medicine Diagnostic (SPECT and PET) Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Manufacturer in 2019
Figure 31. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Nuclear Medicine Diagnostic (SPECT and PET) Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Nuclear Medicine Diagnostic (SPECT and PET) Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Regions (2015-2020)
Figure 38. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Regions in 2018
Figure 39. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
Figure 40. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
Figure 42. South America Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020)
Figure 44. North America Nuclear Medicine Diagnostic (SPECT and PET) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Countries (2015-2020)
Figure 46. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Countries in 2018
Figure 47. North America Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Countries in 2018
Figure 49. United States Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Nuclear Medicine Diagnostic (SPECT and PET) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Countries in 2019
Figure 55. Germany Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Regions 2019
Figure 63. China Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Nuclear Medicine Diagnostic (SPECT and PET) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Countries in 2019
Figure 70. South America Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Countries in 2019
Figure 71. Brazil Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Nuclear Medicine Diagnostic (SPECT and PET) Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Nuclear Medicine Diagnostic (SPECT and PET) Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Nuclear Medicine Diagnostic (SPECT and PET) Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Nuclear Medicine Diagnostic (SPECT and PET) Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Nuclear Medicine Diagnostic (SPECT and PET) Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel

---